4 Medical Devices Behemoths to Buy Amid Extensive AI ApplicationsZacks Investment Research • 08/22/25
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to KnowZacks Investment Research • 08/07/25
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without IncisionsBusiness Wire • 08/06/25
10 stocks favored to gain up to 30% in a sector that has missed this year's rallyMarket Watch • 07/31/25
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock UpZacks Investment Research • 07/23/25
Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/23/25
Boston Scientific Eyes Breakout On Strong Second Quarter, GuidanceInvestors Business Daily • 07/23/25
Boston Scientific (BSX) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 07/23/25
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPSZacks Investment Research • 07/18/25
Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/16/25
Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?Zacks Investment Research • 07/15/25
Boston Scientific (BSX) Crossed Above the 20-Day Moving Average: What That Means for InvestorsZacks Investment Research • 07/11/25